![]() ![]() Most recently, Debbie served as the interim head of human resources for Cubist Pharmaceuticals, Inc., where she was appointed to lead the post-merger human resource integration following the acquisition of Cubist by Merck. ![]() In addition, he received an MBA from Massachusetts Institute of Technology.ĭebbie is an accomplished human resources executive with a focus on providing strategic direction to companies on people matters, managing rapid growth and creating and maintaining high performance cultures. in Organic Chemistry from Harvard University. in Chemistry from Dartmouth College and a Ph.D. patents, and has authored or co-authored numerous peer-reviewed publications. Percy is an inventor or co-inventor on more than 28 U.S. Prior to his experience at BMS, he was Senior Research Scientist in Chemical and Physical Sciences at DuPont Pharmaceuticals, until it was acquired by BMS in 2001. From August 2001 to May 2019, Percy held roles of increasing responsibility in drug discovery, covering all therapeutic areas, drug platforms and stages of discovery at Bristol-Myers Squibb (BMS), including serving as Senior Vice President and Head of Discovery. He previously served as Global Head of Discovery Sciences at Janssen Pharmaceuticals, Inc., a division of Johnson & Johnson, where he led more than 700 employees comprising several key research and discovery functions, and drove the synthetic discovery strategy in collaboration with partners across various therapeutic areas. Prior to joining Blueprint Medicines, he served as Chief Scientific Officer at FibroGen, Inc. Percy brings more than 20 years of global leadership in pharmaceutical companies and industry experience. ![]()
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |